PACS
Pacs Group Inc
NYSE · Health Care
$38.68
+1.81 (+4.91%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 4.31B | 2.84B | 3.14B | 3.12B | 3.43B |
| Net Income | 58.78M | 34.82M | 261.41M | 247.42M | 323.93M |
| EPS | — | — | — | — | — |
| Profit Margin | 1.4% | 1.3% | 8.3% | 7.9% | 9.4% |
| Rev Growth | +51.9% | +51.9% | +15.8% | +21.1% | -3.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 1.33B | 1.33B | 2.19B | 2.33B | 2.03B |
| Total Equity | 1.70B | 1.70B | 2.15B | 2.11B | 2.34B |
| D/E Ratio | 0.78 | 0.78 | 1.02 | 1.11 | 0.87 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 196.80M | 123.07M | 534.50M | 494.05M | 610.91M |
| Free Cash Flow | — | — | 236.72M | 243.03M | 276.91M |